Drugs / buprenorphine/naloxone
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT05644587 Comparator | Feb → Nov 2023 | opiate dependence, opioid abuse | Bicycle Health | Terminated | No outcome recorded Stop: Enrollment |
Press releases naming this drug 9 releases
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | buprenorphine/naloxone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05644587 ↗ |
| Known as | Suboxone | “Buprenorphine/naloxone, also referred to as brand name Suboxone, is administered by placing a film strip under the tongue.” NCT05644587 ↗ |